Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States

Clicks: 512
ID: 118280
2011
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Because current rates of screening and treatment are low, future morbidity and mortality from hepatitis C are likely to increase substantially without public health interventions to increase treatment.
Reference Key
db2011digestiveforecasting Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rein DB;Wittenborn JS;Weinbaum CM;Sabin M;Smith BD;Lesesne SB;;
Journal digestive and liver disease : official journal of the italian society of gastroenterology and the italian association for the study of the liver
Year 2011
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/20739252
Keywords
hepatitis c National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine models research support u.s. gov't adult female male middle aged united states / epidemiology young adult P.H.S. theoretical monte carlo method computer simulation markov chains disease progression forecasting* pmid:20739252 doi:10.1016/j.dld.2010.05.006 david b rein john s wittenborn sarah b lesesne asymptomatic infections / epidemiology* asymptomatic infections / mortality end stage liver disease / epidemiology* end stage liver disease / mortality chronic / epidemiology* chronic / mortality liver transplantation / trends* morbidity / trends

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.